title: Wide-ranging DNA methylation differences of primary trophoblast cell populations and derived cell lines: implications and opportunities for understanding trophoblast function.
abstract: Difficulties associated with long-term culture of primary trophoblasts have proven to be a major hurdle in their functional characterization. In order to circumvent this issue, several model cell lines have been established over many years using a variety of different approaches. Due to their differing origins, gene expression profiles and behaviour in vitro, different model lines have been utilized to investigate specific aspects of trophoblast biology. However, generally speaking, the molecular mechanisms underlying functional differences remain unclear. In this study, we profiled genome-scale DNA methylation in primary first trimester trophoblast cells and seven commonly used trophoblast-derived cell lines in an attempt to identify functional pathways differentially regulated by epigenetic modification in these cells. We identified a general increase in DNA promoter methylation levels in four choriocarcinoma (CCA)-derived lines and transformed HTR-8/SVneo cells, including hypermethylation of several genes regularly seen in human cancers, while other differences in methylation were noted in genes linked to immune responsiveness, cell morphology, development and migration across the different cell populations. Interestingly, CCA-derived lines show an overall methylation profile more similar to unrelated solid cancers than to untransformed trophoblasts, highlighting the role of aberrant DNA methylation in CCA development and/or long-term culturing. Comparison of DNA methylation and gene expression in CCA lines and cytotrophoblasts revealed a significant contribution of DNA methylation to overall expression profile. These data highlight the variability in epigenetic state between primary trophoblasts and cell models in pathways underpinning a wide range of cell functions, providing valuable candidate pathways for future functional investigation in different cell populations. This study also confirms the need for caution in the interpretation of data generated from manipulation of such pathways in vitro.
authors.affiliation: Cancer, Disease and Developmental Epigenetics Group, Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Parkville, Australia.
authors.forename: Boris
authors.initials: B
authors.lastname: Novakovic
authors.forename: Lavinia
authors.initials: L
authors.lastname: Gordon
authors.forename: Nicholas C
authors.initials: NC
authors.lastname: Wong
authors.forename: Ashley
authors.initials: A
authors.lastname: Moffett
authors.forename: Ursula
authors.initials: U
authors.lastname: Manuelpillai
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Craig
authors.forename: Andrew
authors.initials: A
authors.lastname: Sharkey
authors.forename: Richard
authors.initials: R
authors.lastname: Saffery
mesh_terms: D018929:Cell Culture Techniques; D045744:Cell Line, Tumor; D002822:Choriocarcinoma; D019175:DNA Methylation; D057890:Epigenomics; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D014644:Genetic Variation; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D009928:Organ Specificity; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011401:Promoter Regions, Genetic; D014327:Trophoblasts / Q000378:metabolism* / Q000473:pathology; D014594:Uterine Neoplasms / Q000196:embryology / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*